Compare Citius Pharmaceuticals Inc (CTXR) vs Gartner Inc (IT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Gartner Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.52 (market cap $14.83M), while Gartner Inc trades at $132.89 (market cap $9.46B). The key difference: Gartner Inc is far larger — about 637.9× Citius Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| CTXR | IT | |
|---|---|---|
Market Cap | $14.83M | $9.46B |
Sector | Health | Technology |
52-Week High | $1.82 | $363.58 |
52-Week Low | $0.53 | $125.68 |
Enterprise Value | $11.05M | $11.05B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Gartner Inc
Based in Stamford, Conn., Gartner provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services and hosted nearly 80 IT conferences across the globe in 2007.
Read more on IT →
